14
Participants
Start Date
September 1, 2024
Primary Completion Date
September 30, 2024
Study Completion Date
October 15, 2024
PanCytoVir™
PanCytoVir™ 100 mg/mL oral suspension
Vayam Research Solutions Limited, Gujarat
TrippBio, Inc.
INDUSTRY